CASE DISCUSSION
Contemporary Breast Surgery: Sentinel Node & Oncoplasty
Presented by Dr. Tarang PatelViews
1,319
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Contemporary breast surgery has evolved significantly with the integration of sentinel lymph node biopsy (SLNB) and oncoplastic techniques, enabling effective cancer control while preserving breast aesthetics and function. Sentinel node mapping has largely replaced routine axillary lymph node...
Case Summary
- Breast cancer is a significant health concern in India, with a notable difference in patient demographics compared to the Western world, as nearly half of the cases occur in women under 40. Diagnosis in India relies on a combination of clinical examination, mammography, sonography (often integrated), and core needle biopsy, which has replaced cytology due to its improved reliability.
Speaker Profile
Dr. Tarang Patel
Senior Consultant, Breast and Cancer Surgeon, EPIC Multispeciality Hospital, AhmedabadDr. Tarang Patel is a highly experienced Breast and Cancer Surgeon with over two decades of dedicated practice in surgical oncology and breast disease management. He currently serves as Senior Consultant Breast & Cancer Surgeon at EPIC Multispecialty Hospital, Ahmedabad (since July 2024) and has been a Senior Consultant at CIMS Hospital, Ahmedabad since 2016, where he is actively involved in advanced breast cancer surgery and multidisciplinary oncologic care. Earlier, he was the Director and Consultant Cancer & Reconstruction Surgeon at Shrey Hospital, Navrangpura, Ahmedabad (1998–2016), where he played a key role in establishing comprehensive surgical oncology and reconstructive services. Throughout his career, Dr. Patel has been deeply engaged in advancing modern breast cancer management, including breast conservation techniques, oncoplastic surgery, and evolving approaches to axillary management, while contributing to patient-centered cancer care and surgical innovation in the region.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.